One of these first patients to undergo the vaccine’s trial run is Kelly Potter, a 35-year-old British woman who was diagnosed with advanced cervical cancer in July 2015.
“To be part of this trial has changed my life for the better,” she said. “It’s been a very positive experience and really interesting. I feel honored to be involved. You get the best treatment anyway at Guy’s but it’s fantastic to be part of something that could be ground breaking.”
The vaccine will be given to a group of about thirty cancer patients over the next two years. These patients will also receive low doses of a chemotherapy drug.
Researchers at Guy’s Hospital hope that the vaccine will act as a boost for the patients’ suppressed immune systems, working with the chemotherapy to eradicate cancerous cells.
As for Kelly, “My hope for the future is to beat the cancer for as long as I can, and if I can’t, I have come to terms with that. I would like to go on and inspire others with cancer.”
SHARE this and stay tuned for more news about cancer research and prevention!